Everyone is looking forward to the arrival of the vaccine for the novel coronavirus. However, when the vaccine is ready, a fast, reliable and safe logistics process is made necessary. This will ensure successful immunization results. One of the key questions related to vaccines is the importance of temperature maintenance specified by the manufacturer during storage and transportation. In Brazil, Anvisa published a resolution that changes the standard on Good Drug Product Distribution, Storage and Transportation Practices.
BLS Tech has solutions ready to meet new Anvisa resolution for transportation.
The logistics sector for cold chain has been considerably impacted in the past months in view of the new resolutions of the Brazilian Health Regulatory Agency (Anvisa) for distribution of Covid-19 vaccines and pharmaceutical products. With wide experience in the sector, BLS Tech (Biothermal Logistics Solutions), first logtech integrating solutions 100% focused on cold chain, already provides solutions and know-how in the entire process.
Carine Siffert, BLS Quality Manager, was responsible for the speech of Abralog’s monthly Logistics Committee, this Thursday, 06/10/2021. The goal of the presentation was to show the overview of RDC 430/2020, standard that determines the obligation of monitoring, control and temperature maintenance across the supply chain, as per manufacturer specifications.
On this show, Renato Albuquerque talks to Carine Siffer, pharmacist with expertise in cold chain logistics and she tells everything about transportation and safety of COVID vaccine in Brazil. Does it reach the entire country? Is this transportation safe? Watch the full show to see the answers! Watch our TV WEB with shows 24/7, shows dedicated to Career, Business, Culture, Music, Literature, Talk Show, Law and much more. Watch it now!
Dedicated to health cold chain, BLS is joins Abralog for cutting edge logistics
INTERVIEW FÁBIO MARTINS | BLS CEO
Expert in innovation, distribution and release of products in pharmaceutical and cold chain industry, Fábio Martins, CEO and founding partner of BLS Pelican, will tell us on this interview everything about this company, which has just joined Abralog. Martins has over 25 years of experience in B2B markets, including multinationals such as Schering-Plough, Ranbaxy and Glenmark, and took part of start-up of the latter two in Brazil, Argentina, Mexico, Colombia and Peru.
See the challenges for coronavirus mass vaccination
Mass vaccination requires a large structure for transportation, warehousing and storage of immunizing agent. To know if Brazil is ready to properly receive coronavirus vaccine, we talked to an expert in pharmaceutical product logistics, Leandro Gelpke.